No Beneficial Effect of Interferon-γ Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection

Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-γ (IFN-γ) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2001-02, Vol.32 (4), p.e81-e82
Hauptverfasser: Lauw, Fanny N., van der Meer, Jan T. M., de Metz, Jesse, Danner, Sven A., van der Poll, Tom
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e82
container_issue 4
container_start_page e81
container_title Clinical infectious diseases
container_volume 32
creator Lauw, Fanny N.
van der Meer, Jan T. M.
de Metz, Jesse
Danner, Sven A.
van der Poll, Tom
description Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-γ (IFN-γ) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-γ therapy did not produce sustained benefit.
doi_str_mv 10.1086/318705
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70631853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1086/318705</oup_id><sourcerecordid>70631853</sourcerecordid><originalsourceid>FETCH-LOGICAL-i304t-9890795f2426b0f214b402ad367a23739f6cd7fff29a22e714a0927c157bc0d33</originalsourceid><addsrcrecordid>eNqFkUtuFDEQhi1ERB7AEZDZZNfgR_vRSxglmZFCEkFAiI3l7raFoW1PbHeSuQSX4R45U3rSAZZsqn5VffUv6gfgJUZvMJL8LcVSIPYE7GFGRcVZg59OGjFZ1ZLKXbCf8w-EMJaIPQO7eBIY13gP_DqL8L0JxrrO6QEeWWu6AqOFq1BMsibFUN39hpfJ6OJNKNAFSOBy9DrAlfdjiP3DrQndBn5xaczVKmw9TA8vdJnmJcMbV77DD5sutnpaJDd6qK-3dRH9ejC3cD5xMTwHO1YP2bx47Afg8_HR5WJZnZ6frBbvTitHUV2qRjZINMySmvAWWYLrtkZE95QLTaigjeVdL6y1pNGEGIFrjRoiOsxE26Ge0gNwOPuuU7waTS7Ku9yZYdDBxDErgfj0UfZ_EAspeS34BL56BMfWm16tk_M6bdSfV0_A6xmI4_rfFqltfGqOb2KqmXG5mNu_lE4_FRdUMLX8-k19RGfL5hNZKE7vAe_QmUE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17886476</pqid></control><display><type>article</type><title>No Beneficial Effect of Interferon-γ Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lauw, Fanny N. ; van der Meer, Jan T. M. ; de Metz, Jesse ; Danner, Sven A. ; van der Poll, Tom</creator><creatorcontrib>Lauw, Fanny N. ; van der Meer, Jan T. M. ; de Metz, Jesse ; Danner, Sven A. ; van der Poll, Tom</creatorcontrib><description>Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-γ (IFN-γ) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-γ therapy did not produce sustained benefit.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/318705</identifier><identifier>PMID: 11181141</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Adult ; AIDS-Related Opportunistic Infections - drug therapy ; AIDS-Related Opportunistic Infections - microbiology ; Female ; Human immunodeficiency virus ; Humans ; Interferon-gamma - therapeutic use ; Male ; Mycobacterium avium ; Mycobacterium avium Complex ; Mycobacterium avium-intracellulare Infection - drug therapy ; Mycobacterium avium-intracellulare Infection - microbiology ; Treatment Outcome</subject><ispartof>Clinical infectious diseases, 2001-02, Vol.32 (4), p.e81-e82</ispartof><rights>2001 by the Infectious Diseases Society of America 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11181141$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lauw, Fanny N.</creatorcontrib><creatorcontrib>van der Meer, Jan T. M.</creatorcontrib><creatorcontrib>de Metz, Jesse</creatorcontrib><creatorcontrib>Danner, Sven A.</creatorcontrib><creatorcontrib>van der Poll, Tom</creatorcontrib><title>No Beneficial Effect of Interferon-γ Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-γ (IFN-γ) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-γ therapy did not produce sustained benefit.</description><subject>Adult</subject><subject>AIDS-Related Opportunistic Infections - drug therapy</subject><subject>AIDS-Related Opportunistic Infections - microbiology</subject><subject>Female</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Interferon-gamma - therapeutic use</subject><subject>Male</subject><subject>Mycobacterium avium</subject><subject>Mycobacterium avium Complex</subject><subject>Mycobacterium avium-intracellulare Infection - drug therapy</subject><subject>Mycobacterium avium-intracellulare Infection - microbiology</subject><subject>Treatment Outcome</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtuFDEQhi1ERB7AEZDZZNfgR_vRSxglmZFCEkFAiI3l7raFoW1PbHeSuQSX4R45U3rSAZZsqn5VffUv6gfgJUZvMJL8LcVSIPYE7GFGRcVZg59OGjFZ1ZLKXbCf8w-EMJaIPQO7eBIY13gP_DqL8L0JxrrO6QEeWWu6AqOFq1BMsibFUN39hpfJ6OJNKNAFSOBy9DrAlfdjiP3DrQndBn5xaczVKmw9TA8vdJnmJcMbV77DD5sutnpaJDd6qK-3dRH9ejC3cD5xMTwHO1YP2bx47Afg8_HR5WJZnZ6frBbvTitHUV2qRjZINMySmvAWWYLrtkZE95QLTaigjeVdL6y1pNGEGIFrjRoiOsxE26Ge0gNwOPuuU7waTS7Ku9yZYdDBxDErgfj0UfZ_EAspeS34BL56BMfWm16tk_M6bdSfV0_A6xmI4_rfFqltfGqOb2KqmXG5mNu_lE4_FRdUMLX8-k19RGfL5hNZKE7vAe_QmUE</recordid><startdate>20010215</startdate><enddate>20010215</enddate><creator>Lauw, Fanny N.</creator><creator>van der Meer, Jan T. M.</creator><creator>de Metz, Jesse</creator><creator>Danner, Sven A.</creator><creator>van der Poll, Tom</creator><general>The University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20010215</creationdate><title>No Beneficial Effect of Interferon-γ Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection</title><author>Lauw, Fanny N. ; van der Meer, Jan T. M. ; de Metz, Jesse ; Danner, Sven A. ; van der Poll, Tom</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i304t-9890795f2426b0f214b402ad367a23739f6cd7fff29a22e714a0927c157bc0d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>AIDS-Related Opportunistic Infections - drug therapy</topic><topic>AIDS-Related Opportunistic Infections - microbiology</topic><topic>Female</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Interferon-gamma - therapeutic use</topic><topic>Male</topic><topic>Mycobacterium avium</topic><topic>Mycobacterium avium Complex</topic><topic>Mycobacterium avium-intracellulare Infection - drug therapy</topic><topic>Mycobacterium avium-intracellulare Infection - microbiology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lauw, Fanny N.</creatorcontrib><creatorcontrib>van der Meer, Jan T. M.</creatorcontrib><creatorcontrib>de Metz, Jesse</creatorcontrib><creatorcontrib>Danner, Sven A.</creatorcontrib><creatorcontrib>van der Poll, Tom</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lauw, Fanny N.</au><au>van der Meer, Jan T. M.</au><au>de Metz, Jesse</au><au>Danner, Sven A.</au><au>van der Poll, Tom</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No Beneficial Effect of Interferon-γ Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2001-02-15</date><risdate>2001</risdate><volume>32</volume><issue>4</issue><spage>e81</spage><epage>e82</epage><pages>e81-e82</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-γ (IFN-γ) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-γ therapy did not produce sustained benefit.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>11181141</pmid><doi>10.1086/318705</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2001-02, Vol.32 (4), p.e81-e82
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_70631853
source MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects Adult
AIDS-Related Opportunistic Infections - drug therapy
AIDS-Related Opportunistic Infections - microbiology
Female
Human immunodeficiency virus
Humans
Interferon-gamma - therapeutic use
Male
Mycobacterium avium
Mycobacterium avium Complex
Mycobacterium avium-intracellulare Infection - drug therapy
Mycobacterium avium-intracellulare Infection - microbiology
Treatment Outcome
title No Beneficial Effect of Interferon-γ Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T15%3A10%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20Beneficial%20Effect%20of%20Interferon-%CE%B3%20Treatment%20in%202%20Human%20Immunodeficiency%20Virus-Infected%20Patients%20with%20Mycobacterium%20avium%20Complex%20Infection&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Lauw,%20Fanny%20N.&rft.date=2001-02-15&rft.volume=32&rft.issue=4&rft.spage=e81&rft.epage=e82&rft.pages=e81-e82&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/318705&rft_dat=%3Cproquest_pubme%3E70631853%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17886476&rft_id=info:pmid/11181141&rft_oup_id=10.1086/318705&rfr_iscdi=true